RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bavarian Nordic A/S Stock

Bavarian Nordic A/S Revenue 2024

Bavarian Nordic A/S Revenue

5.43 B DKK

Ticker

BAVA.CO

ISIN

DK0015998017

WKN

917165

In 2024, Bavarian Nordic A/S's sales reached 5.43 B DKK, a -23.17% difference from the 7.06 B DKK sales recorded in the previous year.

The Bavarian Nordic A/S Revenue history

YEARREVENUE (undefined DKK)GROSS MARGIN (%)
2029e6.7668,05
2028e6.0476,25
2027e5.6881,00
2026e4.9393,37
2025e4.7796,48
2024e5.4384,83
20237.0665,18
20223.1553,99
20211.930,08
20201.8536,35
20190.6646,45
20180.549,04
20171.3778,79
20161.0170,42
20151.0259,32
20141.2259,31
20131.2160,02
20121.0249,49
20110.5222,96
20100.31-41,52
20090.07-87,30
20080.215,80
20070.3380,58
20060.1822,25
20050.2546,61
20040.1657,34

Bavarian Nordic A/S Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bavarian Nordic A/S, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bavarian Nordic A/S from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bavarian Nordic A/S’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bavarian Nordic A/S. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bavarian Nordic A/S’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bavarian Nordic A/S’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bavarian Nordic A/S’s growth potential.

Bavarian Nordic A/S Revenue, EBIT and net profit per share

DateBavarian Nordic A/S RevenueBavarian Nordic A/S EBITBavarian Nordic A/S Net Income
2029e6.76 B DKK0 DKK0 DKK
2028e6.04 B DKK1.81 B DKK935.22 M DKK
2027e5.68 B DKK1.55 B DKK723.03 M DKK
2026e4.93 B DKK987.87 M DKK784.59 M DKK
2025e4.77 B DKK867.51 M DKK672.51 M DKK
2024e5.43 B DKK911.37 M DKK814.8 M DKK
20237.06 B DKK2.12 B DKK1.48 B DKK
20223.15 B DKK-70.79 M DKK-347.38 M DKK
20211.9 B DKK-312.93 M DKK-464.78 M DKK
20201.85 B DKK395.65 M DKK277.52 M DKK
2019662.49 M DKK-328.45 M DKK-346.78 M DKK
2018500.62 M DKK-354.48 M DKK-361.93 M DKK
20171.37 B DKK353.19 M DKK181.34 M DKK
20161.01 B DKK35.41 M DKK30.6 M DKK
20151.02 B DKK13.55 M DKK59.43 M DKK
20141.22 B DKK16.68 M DKK25.94 M DKK
20131.21 B DKK33.4 M DKK-46.7 M DKK
20121.02 B DKK-31.7 M DKK-240 M DKK
2011523.6 M DKK-308.3 M DKK-268.4 M DKK
2010314.1 M DKK-474.1 M DKK-389.9 M DKK
200974.8 M DKK-341.2 M DKK-266.3 M DKK
2008208.8 M DKK-209.5 M DKK-146.1 M DKK
2007332.1 M DKK-65 M DKK-60 M DKK
2006175.3 M DKK-203.8 M DKK-158 M DKK
2005247.6 M DKK-119.8 M DKK-94.1 M DKK
2004164.8 M DKK-82.3 M DKK-53 M DKK

Bavarian Nordic A/S stock margins

The Bavarian Nordic A/S margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bavarian Nordic A/S. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bavarian Nordic A/S.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bavarian Nordic A/S's sales revenue. A higher gross margin percentage indicates that the Bavarian Nordic A/S retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bavarian Nordic A/S's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bavarian Nordic A/S's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bavarian Nordic A/S's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bavarian Nordic A/S. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bavarian Nordic A/S's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bavarian Nordic A/S Margin History

Bavarian Nordic A/S Gross marginBavarian Nordic A/S Profit marginBavarian Nordic A/S EBIT marginBavarian Nordic A/S Profit margin
2029e65.18 %0 %0 %
2028e65.18 %29.98 %15.49 %
2027e65.18 %27.2 %12.72 %
2026e65.18 %20.04 %15.91 %
2025e65.18 %18.18 %14.1 %
2024e65.18 %16.8 %15.02 %
202365.18 %30.08 %20.89 %
202253.99 %-2.25 %-11.03 %
202130.08 %-16.49 %-24.49 %
202036.35 %21.36 %14.98 %
201946.45 %-49.58 %-52.34 %
201849.04 %-70.81 %-72.3 %
201778.79 %25.78 %13.24 %
201670.42 %3.52 %3.04 %
201559.32 %1.33 %5.82 %
201459.31 %1.37 %2.13 %
201360.02 %2.75 %-3.85 %
201249.49 %-3.12 %-23.61 %
201122.96 %-58.88 %-51.26 %
2010-41.52 %-150.94 %-124.13 %
2009-87.3 %-456.15 %-356.02 %
20085.8 %-100.34 %-69.97 %
200780.58 %-19.57 %-18.07 %
200622.25 %-116.26 %-90.13 %
200546.61 %-48.38 %-38 %
200457.34 %-49.94 %-32.16 %

Bavarian Nordic A/S Aktienanalyse

What does Bavarian Nordic A/S do?

Bavarian Nordic A/S is a biopharmaceutical company based in Denmark, specializing in the development and production of vaccines. The company was established in 1994 as a spin-off from the University of Copenhagen and has been listed on the Copenhagen stock exchange since 1998. The company's history began with an innovation developed by Professor Peter Andersen at the University of Copenhagen - the Viruslike Particles (VLP) technology. This technology serves as the basis for the production of vaccines against severe infectious diseases such as influenza, RSV, or HPV. Bavarian Nordic utilizes this technology to generate effective immune responses without using live pathogens. The company's business model is focused on two areas: the commercial vaccine sector and the biodefense products sector. The commercial sector includes the development and production of vaccines for cancer (such as prostate cancer or breast cancer) as well as infectious diseases like RSV. The biodefense products sector concentrates on protection against biological attacks, with the company manufacturing vaccines against bioweapons such as anthrax or smallpox for governmental institutions. Bavarian Nordic is divided into various business divisions. One of these is the commercial vaccines department, which develops and produces vaccines for the commercial market, particularly for cancer indications. The company also has a biodefense products department, which safeguards governmental institutions and organizations against bioterrorist attacks and other threats posed by biological weapons. This department focuses on the development and production of vaccines against smallpox, anthrax, and Ebola virus. Bavarian Nordic offers a wide range of products. The commercial vaccine Prostvac against prostate cancer is the company's flagship product. Other vaccines that have been developed or are still in development include vaccines against breast cancer, influenza, RSV, and lung cancer. The biodefense products encompass vaccines against smallpox, anthrax, and Ebola virus, as well as preclinical development programs for additional biological attacks. The company has also signed cooperation agreements with other companies to accelerate the research and development of new products. These include collaborations with Bristol Myers Squibb and Janssen Pharmaceutica for the development of cancer vaccines, as well as with the British Ministry of Defence for the development of vaccines against anthrax. Overall, Bavarian Nordic A/S caters to a broad range of interests and business sectors. The company focuses on the development and production of vaccines for both commercial and governmental institutions, aiming to enhance protection against biological threats and infectious diseases. Thanks to its innovative VLP technology, the company is a key player in the field of vaccine development and offers a wide range of products. Bavarian Nordic A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Bavarian Nordic A/S's Sales Figures

The sales figures of Bavarian Nordic A/S originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Bavarian Nordic A/S’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Bavarian Nordic A/S's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Bavarian Nordic A/S’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Bavarian Nordic A/S stock

How much revenue did Bavarian Nordic A/S generate this year?

Bavarian Nordic A/S has achieved a revenue of 5.43 B DKK this year.

How much was the turnover of the company Bavarian Nordic A/S compared to the previous year?

The revenue of Bavarian Nordic A/S has increased by -23.17% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Bavarian Nordic A/S?

The revenue of Bavarian Nordic A/S is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Bavarian Nordic A/S measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Bavarian Nordic A/S so important for investors?

The revenue of Bavarian Nordic A/S is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Bavarian Nordic A/S pay?

Over the past 12 months, Bavarian Nordic A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bavarian Nordic A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bavarian Nordic A/S?

The current dividend yield of Bavarian Nordic A/S is .

When does Bavarian Nordic A/S pay dividends?

Bavarian Nordic A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bavarian Nordic A/S?

Bavarian Nordic A/S paid dividends every year for the past 0 years.

What is the dividend of Bavarian Nordic A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bavarian Nordic A/S located?

Bavarian Nordic A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bavarian Nordic A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bavarian Nordic A/S from 7/28/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 7/28/2024.

When did Bavarian Nordic A/S pay the last dividend?

The last dividend was paid out on 7/28/2024.

What was the dividend of Bavarian Nordic A/S in the year 2023?

In the year 2023, Bavarian Nordic A/S distributed 0 DKK as dividends.

In which currency does Bavarian Nordic A/S pay out the dividend?

The dividends of Bavarian Nordic A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bavarian Nordic A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Bavarian Nordic A/S

Our stock analysis for Bavarian Nordic A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bavarian Nordic A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.